TNI BioTech, a biotech company utilizing patented immunotherapy to activate and mobilize the body’s immune system to combat fatal diseases, today announced that CEO Noreen McGurrin Griffin and CMO Dr. Ronald Herberman will be speaking at the 6th Annual OneMedForum taking place in San Francisco, CA, on January 7-9, 2013.
Ms. Griffin and Dr. Herberman will provide an update on the company’s business activities for 2012 as well as plans for 2013. TNI BioTech’s presentation is scheduled for Wednesday, January 9, 2013, at 11:20 am PST.
For more information on TNI BioTech, visit www.TNIBioTech.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The QualityStocks Daily Blog http://blog.qualitystocks.net
The QualityStocks Video Charts http://videocharts.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment